Twenty years in healthcare, from three sides.

Bring me in and you get two decades of selling and raising in healthcare, from three sides: as an investor, as a founder, and inside a health system.

At J.P. Morgan Asset Management, I trained as an institutional investor, so the work carries real investment rigor and a clear read on how the people writing your checks decide. As a partner at Blueprint Health, I ran four accelerator cohorts; the program's companies include Touch Surgery, RubiconMD, Artemis, and NexHealth. At Junto Health, which I founded and ran for seven years, I worked with the health systems, payers, and pharma that actually buy healthcare technology, and built a consortium of two dozen hospital venture arms that ran 58 deals together.

At Atlantic Health, I designed and led the venture studio, built to the growth strategy the CEO and Board set, bringing institutional investment discipline to the process and leading every deal. The studio did three things at once: it backed the technologies reshaping care (Rad AI, Conceivable Life Sciences, FlyteHealth, Hyro), built new innovation capabilities across the system, and stood up net-new lines of business. Three of the funds named me to their LP advisory committee, and I still advise SpringTide Ventures.

The investor, the founder, the operator inside a health system. You get what those twenty years taught me, pointed at your company.